This is the authors' abstract. We don't add key points for this paper.
Many major human neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS), display axonal pathologies including abnormal accumulations of proteins and organelles. Such pathologies highlight damage to the axon as part of the pathogenic process and, in particular, damage to transport of cargoes through axons. Indeed, we now know that disruption of axonal transport is an early and perhaps causative event in many of these diseases. Here, we review the role of axonal transport in neurodegenerative disease.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Vos et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: